Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

New cytokine-targeted therapies show promise for treating alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Calancardin B may help reduce inflammation in immune cells.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Hydrocortisone 17-butyrate 21-propionate ointment caused reversible side effects like skin issues, weight gain, and organ changes in dogs.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

PTH-CBD agonists may help regrow hair after chemotherapy.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Acitretin effectively improved the woman's skin condition.